Mesa Labs Shares Jump Ahead of Key Date
Mesa Laboratories shares rose 2% to $101.78 Wednesday ahead of its May 27 year-end earnings report, the first under new CEO Siddhartha Kadia. Trading volume reached nearly 88,900 shares. Last quarter, revenue climbed 3.6% and operating income jumped 38%. The company’s Clinical Genomics unit remains pressured by weak China sales and trade tensions.